Subepicardial adipose tissue as a modulator of arrhythmias.
Adipose tissue
Arrhythmias
Extracellular vesicles
Secretome
Subepicardial cardiomyopathy
Subepicardium
Weight loss
miRNA
Journal
Heart rhythm
ISSN: 1556-3871
Titre abrégé: Heart Rhythm
Pays: United States
ID NLM: 101200317
Informations de publication
Date de publication:
18 Oct 2024
18 Oct 2024
Historique:
received:
24
04
2024
revised:
11
10
2024
accepted:
12
10
2024
medline:
21
10
2024
pubmed:
21
10
2024
entrez:
20
10
2024
Statut:
aheadofprint
Résumé
The subepicardial tissue is composed of myocardium, fatty tissue, neurons, inflammatory cells, arteries, veins and lymphatic vessels. These components are intimately related and not separated by a visceral layer. Myocardial function can be altered by invasion of adipose tissue into the myocardium creating structural changes, by electrotonic coupling between myocytes and adipocytes, and in response to epicardial adipose secretome signalling. Paracrine signalling from epicardial adipose tissue to the adjacent myocardium is likely mediated by extracellular vesicles through its cargo of miRNAs, proteins and lipids. Weight loss is the mainstay of the prevention of arrhythmias induced by epicardial adipose tissue. Regression of epicardial adipose tissue in the context of weight loss has been associated with favourable electrophysiological reverse remodeling. Local anti-arrhythmic therapies designed to inhibit constituents of the epicardial adipose secretome or to desensitize the target myocardium remain future therapeutic options.
Identifiants
pubmed: 39427690
pii: S1547-5271(24)03449-0
doi: 10.1016/j.hrthm.2024.10.023
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024. Published by Elsevier Inc.